Nevada Medicaid and Nevada Check Up News (Third Quarter 2024 Provider Newsletter) [Read]

Attention Behavioral Health Providers: Monthly Behavioral Health Training Assistance (BHTA) Webinar Scheduled [See Web Announcement 2009]

Attention All Providers: Requirements on When to Use the National Provider Identifier (NPI) of an Ordering, Prescribing or Referring (OPR) Provider on Claims [Announcement 850]

If you are a Medicaid provider whose revalidation application has not been processed by your termination due date, you will be ineligible to provide services to any Nevada Medicaid or Nevada Check Up recipients, including both Fee-for-Service and Managed Care Organization (MCO) enrolled recipients. See Web Announcement 1265

Enrollment Termination Frequently Asked Questions (FAQs) [Review]

Featured Links

DHCFP EVV

Authorization Criteria

DHCFP Home

EDI Information

EVS User Manual

Provider Flex

Online Provider Enrollment

Provider Login (EVS)

Prior Authorization

Search Fee Schedule

Search Providers

Claims

Trading Partner

Self-Paced Training Videos

Notifications


Unwinding COVID-19 Information

Known System Issues-Click HERE

Paper claims are no longer accepted by Nevada Medicaid. Please refer to Web Announcement 1733 and Web Announcement 1829 for additional information.

Top 10 Claim Denial Reasons and Resolutions/Workarounds for September 2024 Professional Claims. See Web Announcement 3465.

Top Enrollment Return Reasons and Resolutions for January 2024 Submissions. See Web Announcement 3350.

Top Prior Authorization Denial Reasons for the Third Quarter of 2024. See Web Announcement 3488.

Attention Providers Using the Authorization Criteria Function: Results that return prior authorization (PA) requirements are accurate. For results that return “There are no records found based on the search criteria,” there may be a PA requirement if limits have been exceeded. To verify PA requirements, please refer to the Medicaid Services Manual (MSM) Chapter for your service type at dhcfp.nv.gov and the Billing Guide for your provider type at www.medicaid.nv.gov.

Provider Links

DHCFP EVV

Billing Information

Forms

Provider Enrollment

Provider Newsletters

Provider Training

Scheduled Site Maintenance

During the scheduled site maintenance window the Provider Web Portal will be unavailable. The table below shows the regularly scheduled maintenance window. All times will be in the Pacific time zone.

Monday - Friday
12:00AM - 12:30AM

Monday
8:00PM - 12:00AM

2015 P&T Pharmacy Meetings

Notice Date Title
December 2015 For Review at December 3, 2015, Meeting: Alzheimer’s Agents
December 2015 For Review at December 3, 2015, Meeting: Intranasal Calcitonins
December 2015 For Review at December 3, 2015, Meeting: Intranasal Histamine H1-receptor Antagonists (Antihistamines)
December 2015 For Review at December 3, 2015, Meeting: Ophthalmic Antihistamines
December 2015 For Review at December 3, 2015, Meeting: Ophthalmic Nonsteroidal Anti-Inflammatory Drugs
December 2015 For Review at December 3, 2015, Meeting: Ophthalmic Steroids
December 2015 For Review at December 3, 2015, Meeting: Oral Atypical (Second-Generation) Antipsychotics
December 2015 For Review at December 3, 2015, Meeting: Platelet Inhibitors
December 2015 For Review at December 3, 2015, Meeting: 5-HT1 Receptor Agonists
December 2015 For Review at December 3, 2015, Meeting: Short-acting B2-Agonists
December 2015 For Review at December 3, 2015, Meeting: Topical Immunomodulators
December 2015 For Review at December 3, 2015, Meeting: Urinary Antispasmodics
September 2015 For Review at September 24, 2015, Meeting: Androgens (testosterone)
September 2015 For Review at September 24, 2015, Meeting: Anticonvulsants
September 2015 For Review at September 24, 2015, Meeting: Beta-adrenergic antagonists (single-entity)
September 2015 For Review at September 24, 2015, Meeting: Colony Stimulating Factors
September 2015 For Review at September 24, 2015, Meeting: Corlanor® (Ivabradine)
September 2015 For Review at September 24, 2015, Meeting: Diclegis® (doxylamine succinate/pyridoxine hydrochloride)
September 2015 For Review at September 24, 2015, Meeting: Immunomodulators
June 2015 For Review at June 25, 2015, Meeting: Insulins
June 2015 For Review at June 25, 2015, Meeting: Multiple Sclerosis Agents
June 2015 For Review at June 25, 2015, Meeting: Omega-3 Fatty Acids
June 2015 For Review at June 25, 2015, Meeting: Onychomycosis Agents
June 2015 For Review at June 25, 2015, Meeting: Opioid Dependence Agents
June 2015 For Review at June 25, 2015, Meeting: Opioids, Long Acting
June 2015 For Review at June 25, 2015, Meeting: Oral Anticoagulants
June 2015 For Review at June 25, 2015, Meeting: Phosphorus Depleters
June 2015 For Review at June 25, 2015, Meeting: Sodium-glucose Co-transporters 2 Inhibitors
March 2015 For Review at March 26, 2015, Meeting: Androgens (testosterone)
March 2015 For Review at March 26, 2015, Meeting: Antidiabetic Agents (Dopamine Agonists)
March 2015 For Review at March 26, 2015, Meeting: Antiemetics (5-HT3 Receptor Antagonists and Combinations)
March 2015 For Review at March 26, 2015, Meeting: Beta Agonists: Inhaled, Single Entity Agents, Long Acting
March 2015 For Review at March 26, 2015, Meeting: Hepatitis C Antivirals and Combinations, Direct Acting
March 2015 For Review at March 26, 2015, Meeting: Incretin Mimetics
March 2015 For Review at March 26, 2015, Meeting: Inhaled Antibiotics (Cystic Fibrosis)
March 2015 For Review at March 26, 2015, Meeting: Inhaled Anticholinergics
March 2015 For Review at March 26, 2015, Meeting: Inhaled Corticosteroids
March 2015 For Review at March 26, 2015, Meeting: Opioid Dependence Agents
March 2015 For Review at March 26, 2015, Meeting: Opioids, Long Acting
March 2015 For Review at March 26, 2015, Meeting: Pancreatic Enzymes
March 2015 For Review at March 26, 2015, Meeting: Pulmonary Arterial Hypertension Agents
March 2015 For Review at March 26, 2015, Meeting: Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors
March 2015 For Review at March 26, 2015, Meeting: Ulcerative Colitis Agents

Return to Past Meeting Reports.